Center news & funding
Eleven VCU Massey Cancer Center research members will receive funding to quickly pivot or expand their work to address the impact of the COVID-19 pandemic on the health system and the community.
Massey researcher recognized for substantial contributions to the field of biostatistical research methodology and oral health epidemiology
Dipankar Bandyopadhyay, Ph.D., a research member at VCU Massey Cancer Center and the director of Massey’s Biostatistics Shared Resource core, has been selected by the Washington Statistical Society and RTI International as the 2020 Gertrude M. Cox awardee.
Robert Winn, M.D., began as director of VCU Massey Cancer Center in December 2019 and has quickly hit the ground running to enact an ambitious agenda. Since early March he has also led Massey’s response to the COVID-19 pandemic affecting the lives of many patients and families. Protecting cancer patients and team members has been his top priority during the rapidly evolving situation, but he is also working to ensure that Massey can continue its cancer research and laying the groundwork for his future vision.
Massey researcher Xiang-Yang (Shawn) Wang, Ph.D., has been appointed as the co-leader of the Developmental Therapeutics (DT) research program at VCU Massey Cancer Center. He will serve in this role alongside Steven Grant, M.D., who has co-led the program since 2011, and Anthony Faber, Ph.D., who has co-led the program since 2018.
For the ninth year, oncology care providers and clinical cancer researchers from across the state gathered for VCU Massey Cancer Center’s Cancer Symposium and Clinical Research Affiliation Network Retreat. This year’s events were held on March 7 at Jonah L. Larrick Student Center on the downtown MCV campus.